UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055357
Receipt number R000058376
Scientific Title Effectiveness of an Online Self-Care Educational Program for Breast Cancer-Related Lymphedema: A Randomized Pilot Study
Date of disclosure of the study information 2024/09/01
Last modified on 2025/02/27 10:11:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effectiveness of an Online Self-Care Educational Program for Breast Cancer-Related Lymphedema: A Randomized Pilot Study

Acronym

Effectiveness of an Online Self-Care Educational Program for Breast Cancer-Related Lymphedema: A Randomized Pilot Study

Scientific Title

Effectiveness of an Online Self-Care Educational Program for Breast Cancer-Related Lymphedema: A Randomized Pilot Study

Scientific Title:Acronym

Effectiveness of an Online Self-Care Educational Program for Breast Cancer-Related Lymphedema: A Randomized Pilot Study

Region

Japan


Condition

Condition

Breast Cancer-Related Lymphedema

Classification by specialty

Breast surgery Rehabilitation medicine Nursing

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect of a six-month online exercise program on symptoms of breast cancer-related lymphedema.

Basic objectives2

Others

Basic objectives -Others

To evaluate the effects of a six-month online exercise program on health-related quality of life (QOL) and self-care adherence in patients with breast cancer-related lymphedema.

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Percent change in total breast cancer-related lymphedema symptom score

Key secondary outcomes

Health related Quality of life
Self-care adherence


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Pseudo-randomization


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Participants in the intervention group will be directed to a dedicated website for the intervention. On this website, they will engage in a six-month program to learn and practice exercises as well as standard BCRL self-care routines.
Exercises are to be completed twice a day at times chosen by the participants.
Daily activities such as measuring weight (once a day), skin care (three times a day), exercise, and applying compression therapy as needed will be recorded on a self-care check sheet.
Once a month, participants will share and discuss their lymphedema and self-care progress with other members of their group during a small-group online salon.

Interventions/Control_2

Participants in the control group will be directed to a website designated for the control group.
On this website, they will learn and practice standard BCRL self-care for six months.
Daily activities such as measuring weight (once a day), skin care (three times a day), exercise, and applying compression therapy as needed will be recorded on a self-care check sheet.
Once a month, participants will share and discuss their lymphedema and self-care progress with other members of their group during a small-group online salon.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >=

Gender

Female

Key inclusion criteria

Aged 18 years or older at the time of consent.
Have undergone surgery for breast cancer treatment.
Experiencing lymphedema symptoms (swelling in the upper body on the side of the surgery) for at least three months after breast cancer treatment.
Able to access the study website daily.
Able to attend an online salon once a month.

Key exclusion criteria

Has recurrent breast cancer or any other type of cancer.
Has received radiation or chemotherapy within the past six months, or plans to receive such treatments during the study period.
Has an infection, inflammation, or deep vein thrombosis in the arm on the side of the surgery.
Is unable to complete online questionnaires.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Yoko
Middle name
Last name Arinaga

Organization

Fukushima medical university

Division name

Faculty of nursing

Zip code

960-1295

Address

1Hikariga-oka, Fukushima City 960-1295, JAPAN

TEL

0245471111

Email

arinaga@aimedicalri.com


Public contact

Name of contact person

1st name Yoko
Middle name
Last name Arinaga

Organization

Fukushima medical university

Division name

Faculty of nursing

Zip code

960-1295

Address

1Hikariga-oka, Fukushima City 960-1295, JAPAN

TEL

0245471111

Homepage URL

https://project-gembcrl.com/

Email

arinaga@aimedicalri.com


Sponsor or person

Institute

Fukushima medical university

Institute

Department

Personal name

Yoko Arinaga


Funding Source

Organization

Japan Science and Technology Agency

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor

Teikyou University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fukushima medical university

Address

1Hikariga-oka, Fukushima City 960-1295, JAPAN

Tel

0245471111

Email

rs@fmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 08 Month 21 Day

Date of IRB

2024 Year 08 Month 27 Day

Anticipated trial start date

2024 Year 09 Month 10 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 08 Month 28 Day

Last modified on

2025 Year 02 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058376